Literature DB >> 2407543

Prevalance of antibodies to 15 antigens of Legionellaceae in patients with community-acquired pneumonia.

M McIntyre1, J B Kurtz, J B Selkon.   

Abstract

Sera from 252 patients with community-acquired pneumonia were examined for the presence of antibodies to 15 antigens of 7 Legionella spp. by indirect immunofluorescent antibody testing. The sera had been collected as part of the British Thoracic Society/Public Health Laboratory Service study of community-acquired pneumonia in adults. We also examined sera from 20 patients with gram-negative sepsis. Using a limited range of antigens of L. pneumophila, nine cases of legionellosis were diagnosed in the original study. However, using antigens to other Legionella spp., we identified two further cases, caused by L. micdadei and L. gormanii respectively. Twenty-six other patients had titres of 16 or 32 to one or more antigens, most commonly L. bozemanii serogroup 1, L. micdadei and L. dumoffi. None of the patients with non-legionella pneumonia, however, had significant changes in legionella antibody titres. All of the patients with Gram-negative sepsis had titres of less than 16.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2407543      PMCID: PMC2271736          DOI: 10.1017/s0950268800054509

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  11 in total

1.  Measure of immunoglobulin G-, M-, and A-specific titers against Legionella pneumophila and inhibition of titers against nonspecific, gram-negative bacterial antigens in the indirect immunofluorescence test for legionellosis.

Authors:  H W Wilkinson; C E Farshy; B J Fikes; D D Cruce; L P Yealy
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

2.  Formalised yolk sac antigen in early diagnosis of Legionnaires' disease caused by Legionella pneumophila serogroup 1.

Authors:  A G Taylor; T G Harrison
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

3.  Prevalence of anti-Legionella antibodies in a healthy population and in patients with tuberculosis or pneumonia.

Authors:  N Bornstein; N Janin; G Bourguignon; M Surgot; J Fleurette
Journal:  Isr J Med Sci       Date:  1986-10

4.  False positive reactions in the indirect fluorescent antibody test for Legionnaires' disease eliminated by use of formolised yolk-sac antigen.

Authors:  A G Taylor; T G Harrison; M W Dighero; C M Bradstreet
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

5.  Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease.

Authors:  J E McDade; C C Shepard; D W Fraser; T R Tsai; M A Redus; W R Dowdle
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

6.  Legionnaires' disease in pneumonia patients in Iowa. A retrospective seroepidemiologic study, 1972-1977.

Authors:  E D Renner; C M Helms; W J Hierholzer; N Hall; Y W Wong; J P Viner; W Johnson; W J Hausler
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

7.  Relation of Mycoplasma pneumoniae seroreactivity, immunosuppression, and chronic disease to Legionnaires' disease. A twelve-month prospective study of sporadic cases in Massachusetts.

Authors:  G F Grady; R F Gilfillan
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

8.  Reactivity of serum from patients with suspected legionellosis against 29 antigens of legionellaceae and Legionella-like organisms by indirect immunofluorescence assay.

Authors:  H W Wilkinson; A L Reingold; B J Brake; D L McGiboney; G W Gorman; C V Broome
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

9.  Cross-reactions between Legionella pneumophila (serogroup 1) and twenty-eight other bacterial species, including other members of the family Legionellaceae.

Authors:  M T Collins; F Espersen; N Høiby; S N Cho; A Friis-Møller; J S Reif
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

10.  Agglutinating antibody titers to members of the family Legionellaceae in cystic fibrosis patients as a result of cross-reacting antibodies to Pseudomonas aeruginosa.

Authors:  M T Collins; J McDonald; N Høiby; O Aalund
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

View more
  1 in total

Review 1.  Legionella and Legionnaires' disease: 25 years of investigation.

Authors:  Barry S Fields; Robert F Benson; Richard E Besser
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.